TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Intake Breathing received a $62 million investment from Camino Partners, the firm founded by Kind creator Daniel Lubetzky. The family-run company says it will use the funding to expand into physical retail and specialty channels and make key hires; the investment terms and rollout timetable were not reported.
Intake Breathing has received a $62 million investment from Camino Partners, the firm founded by Kind Snacks creator Daniel Lubetzky, as the family-run nasal-device company prepares to expand into physical retail and specialty channels. Intake says the funding will support that expansion and new hires, marking its first significant outside capital infusion.
Intake makes a magnetic nasal dilator intended to open the nasal passages. Its system uses a reusable magnetic band and adhesive tabs to mechanically open the nasal valve, which the company describes as the narrowest part of the nasal airway. The design differs from conventional adhesive nasal strips, though the source report does not provide comparative clinical evidence or quantified outcomes for either product type.
The company has built its business mainly through direct-to-consumer sales. It says the new capital will help it reach customers through physical retail and specialty channels and make key hires to support growth. The report does not specify which retailers Intake is targeting, how the money will be allocated, or when new products or stores may become available.
Camino is investing as consumer interest grows around sleep, recovery and performance, according to the report. Intake has drawn attention from professional athletes, including Los Angeles Dodgers pitcher Justin Wrobleski and Belgian soccer player Amadou Onana. Their association with the brand is not evidence of the product’s effectiveness, and the source does not describe either athlete’s use or results.
A Retail Push for Nasal Devices
The investment gives Intake resources to pursue a broader customer base beyond online sales. Moving into physical retail and specialty outlets could make the product easier for consumers to encounter alongside existing wellness and breathing aids. Whether that expansion succeeds will depend on retailer interest, customer demand and the company’s ability to support wider distribution; none of those outcomes is established by the funding announcement.
For Camino, the deal is a bet that nasal-breathing products can move from a niche category into more routine consumer health and wellness purchases. Lubetzky compared the opportunity with Kind’s effort to make healthier snacks more widely appealing. That is Camino’s investment thesis, not a confirmed forecast of market growth or a guarantee that consumers will adopt Intake’s device.
Products Worth Considering
Fitbit Sense Advanced Smartwatch – Sage Grey/Silver (One Size, S & L Bands Included)
Fitbit Versa Smart Watch – Black Aluminum, One Size (S & L Bands Included)
Fitbit Versa 2 Health and Fitness Smartwatch with Bonus Bands
As an affiliate, we earn on qualifying purchases.
From Family Business to Outside Capital
Intake was founded by inventor and medical-device engineer Jim Castillo and is led by his son-in-law, co-founder and chief executive Alex Hauck. The company began as a family business and, according to the report, had not previously received a significant outside capital infusion. The $62 million investment marks a change in its financing and gives it a partner with experience in consumer brands.
Camino’s portfolio includes boutique fitness company Barry’s and nonalcoholic beer maker Athletic Brewing, among other health-oriented businesses. The investment adds a breathing-products company to that group. Camino president Elle Lanning said the firm sees potential to reposition nasal strips from a traditional drugstore item as part of consumers’ wider wellness routines.
““We’re not just gaining capital, we’re gaining a partner who knows exactly what it takes to help get us there.””
— Alex Hauck, Intake Breathing co-founder and CEO
Terms, Evidence and Rollout Remain Unreported
The source report does not disclose the investment’s ownership terms, valuation, or detailed funding allocation. It also gives no schedule for retail launches, names of retail partners, or hiring plans. Those details will determine how quickly the company can carry out its stated expansion, but they have not been provided.
The report describes Intake’s device design and its commercial ambitions, but does not cite clinical studies establishing that it improves breathing, sleep, athletic performance or recovery. The investment and athlete associations should not be read as proof of health or performance benefits. Independent evidence and product-specific outcome data were not included in the source material.
Retail Expansion Is the Next Test
Intake says it plans to use the capital to enter physical retail and specialty channels and hire for growth. The next visible milestones are likely to be announcements of retail partners, product availability and new team appointments, but the company has not given dates or confirmed specific plans beyond its broad expansion goals.
As those details emerge, the key questions will be how widely the device becomes available and whether consumers adopt it beyond the company’s existing direct-sales audience. For now, the confirmed development is the $62 million investment and Intake’s stated intention to expand; its commercial results remain to be seen.
Key Questions
Who invested in Intake Breathing?
Camino Partners, the investment firm founded by Kind Snacks creator Daniel Lubetzky, invested $62 million in Intake Breathing.
What does Intake Breathing make?
Intake sells a magnetic nasal dilator using a reusable band and adhesive tabs. The company says the device is designed to mechanically open the nasal valve.
How will Intake use the investment?
The company says it will use the funding to expand into physical retail and specialty channels and make key hires. It has not released a detailed budget or timetable.
Does the investment prove the device improves sleep or performance?
No. The source report does not provide clinical evidence showing that the device improves sleep, recovery or athletic performance. The investment and athlete associations are not proof of those effects.
Source: athletechnews.com
